Clinical study of KW oral adjuvant immunotherapy for Japanese cedar pollinosis
Phase 2
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-UMIN000007177
- Lead Sponsor
- Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Use of any anti-histamine drugs, anti-allergy drugs, nasal steroid drugs et al at the beginning of the study, 2) Buildup phase of immunotherapy to Japanese cedar pollen, 3) Pregnancy, potential pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method